secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001171843-24-002427
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose Biosciences amends employment agreements with CEO, CMO, and CFO to harmonize change of control provisions
--------------------------------------------------------------------------------

- CEO William Rice's base salary increased to $648,960, with bonus up to 55% of base and auto allowance of $18,000.
- CMO Rafael Bejar's salary increased to $509,600, added Senior VP title, and updated severance for change of control.
- CFO Fletcher Payne's salary increased to $479,440, added Chief Business Officer and Corporate Secretary titles.
- Each amendment harmonizes change of control provisions and updates compensation terms for the three executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184324002427/0001171843-24-002427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184324002427/f8k_050124.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer